.
MergerLinks Header Logo

New Deal


Announced

Rivean Capital-backed To-Increase completed the acquisition of AX for Pharma.

Synopsis

Rivean Capital-backed To-Increase, a business software solutions provider, completed the acquisition of AX for Pharma, an integrated ERP solution provider for the pharmaceutical industry. Financial terms were not disclosed. "Today’s announcement is a testament to our teams’ exceptional work in empowering and digitalizing pharmaceutical, biotech, and medical device companies worldwide. We will leverage To Increase’s platform to reach and support our existing and new customers globally with our combined industry-leading solutions for life sciences. A special thanks to Luciano and the leadership team at To-Increase who made this possible,” Andrea Ruosi, AX for Pharma CEO.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US